DCGI approves phase 2, 3 trials of ‘Covaxin’ on 2 to 18 year-olds

Name: DCGI approves phase 2, 3 trials of ‘Covaxin’ on 2 to 18 year-olds
Uploaded: 2021-05-13T11:15:58+00:00
Duration: 1 min 7 s
Channel: Deccan Herald
Description: Drugs Controller General of India (DCGI) gave nod to Hyderabad-based Bharat Biotech’s ‘Covaxin’ for phase 2 and 3 trials on 2 to 18 year-olds on May 13. The trial will be conducted in 525 healthy volunteers. In the ongoing vaccination drive in India, the ‘Covaxin’ is being used in adults. ‘Covaxin’ is one of the two vaccines being manufactured in India currently.

Deccan Herald

Drugs Controller General of India (DCGI) gave nod to Hyderabad-based Bharat Biotech’s ‘Covaxin’ for phase 2 and 3 trials on 2 to 18 year-olds on May 13. The trial will be conducted in 525 healthy volunteers. In the ongoing vaccination drive in India, the ‘Covaxin’ is being used in adults. ‘Covaxin’ is one of the two vaccines being manufactured in India currently.

Recommended

Deccan Herald

Coronavirus Outbreak

Featured channels